GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Novel Strategies for Pancreatic Cancer Treatment

$367,221
Jennifer D Black · University Of Nebraska Medical Center · P50 · FY2018 · CA

Targeting Metabolic Alterations to Improve Survival in Pancreatic Cancer

$367,220
Pankaj Kumar Singh · University Of Nebraska Medical Center · P50 · FY2018 · CA

Personalization of graphical models using multi-omics data for subtype discovery and prognosis

$367,210
Tin C Nguyen · Auburn University At Auburn · U01 · FY2024 · CA

Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response

$367,205
Harrison Kim · University Of Alabama At Birmingham · UG3 · FY2020 · CA

Animal Core Facility

$367,189
Bin Guo · North Dakota State University · P20 · FY2018 · GM

Spread of Replicating Adenovirus in Pancreatic Tumors

$367,188
John G. Hay · New York University School Of Medicine · R01 · FY2006 · CA

DNA Repair Pathways Choice to Regulate Therapeutic Resistance in Cancer Cells

$366,954
Zihua Gong · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · CA

Molecular Response and Imaging-based Combination Strategies for Optimal PDT

$366,904
Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2019 · CA

The role of fibroblasts in the activities of tissue penetrating peptides

$366,856
Kazuki Sugahara · Columbia University Health Sciences · R01 · FY2014 · CA

DNA replication linked chromatin assembly in yeast

$366,850
Paul D. Kaufman · Univ Of Massachusetts Med Sch Worcester · R01 · FY2007 · GM

Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer

$366,825
Benjamin Allen · University Of Michigan At Ann Arbor · R01 · FY2019 · CA

ADAM17 in pancreatic cancer and pancreatitis

$366,727
Howard C Crawford · Mayo Clinic Jacksonville · R01 · FY2013 · CA

Function of TbRIII as a BMP Co-receptor in Human Cancer

$366,719
Gerard C Blobe · Duke University · R01 · FY2010 · CA

Targeting the liver for immunotherapy in pancreatic cancer

$366,641
Gregory L Beatty · University Of Pennsylvania · R01 · FY2024 · CA

PQB3: Mechanisms & Targeting of Sonic Hedgehog Signaling in Muscle Wasting of Cancer Cachexia

$366,552
Teresa A Zimmers · Indiana University Indianapolis · R01 · FY2015 · CA

NRF2-dependent redox signaling in pancreatic cancer

$366,525
Christine Iok In Chio · Columbia University Health Sciences · R01 · FY2020 · CA

NRF2-dependent redox signaling in pancreatic cancer

$366,403
Christine Iok In Chio · Columbia University Health Sciences · R01 · FY2021 · CA

Project 3 - Improving Therapy for DNA-Damage Deficient Pancreatic Adenocarcinoma

$366,382
Brian Matthew Wolpin · Dana-Farber Cancer Inst · P50 · FY2022 · CA

A Predictive Modeling Framework to Dissect the Dynamic Immunometabolic Responses to Pathogenic infection and the Kinetic Reprogramming of Metabolism in Cancer Cell System

$366,372
Rajib Saha · University Of Nebraska Lincoln · R35 · FY2024 · GM

Heparanase in Tumor Progression, Metastasis and Chemoresistance

$366,354
Ralph D Sanderson · University Of Alabama At Birmingham · R01 · FY2017 · CA

Nanotechnology Platforms for the Prevention and Personalized Therapy of Pancreati

$366,300
Craig D Logsdon · University Of Texas Hlth Sci Ctr Houston · U54 · FY2010 · CA

NRF2-dependent redox signaling in pancreatic cancer

$366,278
Christine Iok In Chio · Columbia University Health Sciences · R01 · FY2022 · CA

The Pancreatic Cancer Microenvironment

$366,246
Rui Kang · Ut Southwestern Medical Center · R01 · FY2023 · CA

The Evolution of PGD addiction in Human Pancreatic Cancer

$366,237
Oliver Gene McDonald · Vanderbilt University Medical Center · R01 · FY2020 · CA

The RAS and P13K Pathways in Pancreatic Adenocarcinoma

$366,179
Lewis C Cantley · Dana-Farber Cancer Inst · P01 · FY2007 · CA